SCHEMBL8106811

SCHEMBL8106811

NC(=O)[C@H](Cc1ccccc1)NN1C(=O)c2ccccc2C1=O

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.58
▸ POLB P06746 2/20 0.58
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.45
▸ ELANE P08246 1/20 0.44
▸ EPHX1 P07099 1/20 0.44
▸ HPGDS O60760 4/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ PARP3 Q9Y6F1 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27544391 1.00 ALDH1A1 (0.58) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL7272751 0.88 ALDH1A1 (0.56) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL7265100 0.88 ALDH1A1 (0.56) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL8787182 0.85 ALDH1A1 (0.50) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL8787113 0.84 ALDH1A1 (0.49) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL8787955 0.79 ALDH1A1 (0.47) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL7301260 0.74 MME (0.44) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL23578402 0.74 BACE1 (0.48) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL23578399 0.74 BACE1 (0.48) ALDH1A1L3MBTL1POLBMEN1KMT2A
SCHEMBL9391159 0.74 EPHX1 (0.55) KMT2AELANEEPHX1HPGDSPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1495186-A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate ���µ�˹ҩ�﹫˾ 2004-05-12 — — CN disclosed
CN-1113894-C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof AVENTIS PHARMA INC (US) 2003-07-09 — — CN disclosed
EP-0800527-B1 NOVEL PROCESSES FOR PREPARING INTERMEDIATES OF INHIBITORS OF ENKEPHALINASE AND ANGIOTENSIN CONVERTING ENZYME AND INTERMEDIATES THEREOF HOECHST MARION ROUSSEL INC (US) 2000-03-08 — — EP disclosed
EP-0957109-A2 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof HOECHST MARION ROUSSEL, INC. (US) 1999-11-17 — — EP disclosed
US-5872251-A Process for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof HOECHST MARION ROUSSEL, INC. (US) 1999-02-16 — — US disclosed
US-5859252-A Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof HOECHST MARION ROUSSEL, INC. (US) 1999-01-12 — — US disclosed
US-5849908-A Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof HOECHST MARION ROUSSEL INC. (US) 1998-12-15 — — US disclosed
US-5734049-A Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof HOECHST MARION ROUSSEL, INC. (US) 1998-03-31 — — US disclosed
CN-1170413-A Process for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof HOECHEST MARION ROUSSEL INC (US) 1998-01-14 — — CN disclosed
EP-0800527-A1 NOVEL PROCESSES FOR PREPARING INTERMEDIATES OF INHIBITORS OF ENKEPHALINASE AND ANGIOTENSIN CONVERTING ENZYME AND INTERMEDIATES THEREOF HOECHST MARION ROUSSEL, INC. (US) 1997-10-15 — — EP disclosed
US-5641880-A Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof HOECHST MARION ROUSSEL, INC. (US) 1997-06-24 — — US disclosed
WO-1996019492-A1 NOVEL PROCESSES FOR PREPARING INTERMEDIATES OF INHIBITORS OF ENKEPHALINASE AND ANGIOTENSIN CONVERTING ENZYME AND INTERMEDIATES THEREOF HOECHST MARION ROUSSEL, INC. (US) 1996-06-27 — — WO disclosed
Send feedback